CN102507951A - Enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on tumor marker - Google Patents

Enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on tumor marker Download PDF

Info

Publication number
CN102507951A
CN102507951A CN2011103808350A CN201110380835A CN102507951A CN 102507951 A CN102507951 A CN 102507951A CN 2011103808350 A CN2011103808350 A CN 2011103808350A CN 201110380835 A CN201110380835 A CN 201110380835A CN 102507951 A CN102507951 A CN 102507951A
Authority
CN
China
Prior art keywords
enzyme
nse
cyfra21
dkk1
hole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011103808350A
Other languages
Chinese (zh)
Other versions
CN102507951B (en
Inventor
臧林泉
刘大路
潘雪刁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Pharmaceutical University
Original Assignee
Guangdong Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Pharmaceutical University filed Critical Guangdong Pharmaceutical University
Priority to CN201110380835.0A priority Critical patent/CN102507951B/en
Publication of CN102507951A publication Critical patent/CN102507951A/en
Application granted granted Critical
Publication of CN102507951B publication Critical patent/CN102507951B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses an enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on a tumor marker. The ELISA kit consists of a perforated plate coated with neuron specific enolase (NSE), a cytokeratin fragment 21-1 (CYFRA21-1) and a Dkkopf 1 (DKK1) monoclonal antibody, horseradish peroxidase-labeled NSE, horseradish peroxidase-labeled CYFRA21-1, horseradish peroxidase-labeled DKK1, a chromogenic substrate TMB and a substrate stop solution. The ELISA kit has the advantages of simplicity, convenience, sensitivity, stability, high repeatability and the like and has practical value.

Description

A kind of enzyme-linked immunologic detecting kit of joint-detection tumor markers
Technical field
The present invention relates to the detection kit field, be specifically related to a kind of enzyme-linked immunologic detecting kit of joint-detection tumor markers.
Background technology
Lung cancer is one of malignant tumour that the most common deadly number is maximum in the world wide, and its incidence of disease growth rate also is in first of each malignant tumour, because the concealment of lung cancer onset.Still lack examination effectively and method of early diagnosis at present; It is to be mostly late period that symptom appears in the patient, and prognosis is relatively poor, must survive in 5 years in being no more than 15%; The symptom is arranged less than 10%; But in the patients with lung cancer of diagnosis, the prognosis of operative treatment has clear improvement medium and advanced lung cancer in early days, and its survival rate can reach 70%.Methods such as traditional clinically diagnostic method such as rabat, bronchoscope, phlegm cytology checking.But lack enough specificitys and sensitivity.Therefore, be badly in need of a kind of method that can be directed against the lung cancer early diagnosis clinically.At present, be by enzyme linked immunological kit for the more simple and efficient method of lung cancer early diagnosis, and all be to detect both at home and abroad to a certain mark of lung cancer for the kit of pulmonary cancer diagnosis; But lung cancer does not have a species specific marker for lung cancer up till now; All be some relevant labels, owing to the lung cancer complicated classification, the expression of different pathological mark in period is different simultaneously; Just diagnose, can bring greatly mistaken diagnosis situation to a certain mark.
The enzyme linked immunological kit joint-detection that is adopted at present is to operate the ELISA Plate of several kinds of marks simultaneously, has reached the purpose of joint-detection, and this kind operation can bring very big personal error.
Summary of the invention
The objective of the invention is to according to problems such as the personal error that exists in the existing detection kit are big; A kind of kit that can be simultaneously on an ELISA Plate, two or three mark be carried out simultaneously detection by quantitative is provided; Can eliminate personal error, have advantage easy and simple to handle, with low cost concurrently.
Another purpose of the present invention is to provide the preparation method of above-mentioned detection kit.
A further object of the invention is to provide the application of above-mentioned detection kit.
Above-mentioned purpose of the present invention is achieved through following technical scheme:
A kind of enzyme-linked immunologic detecting kit of joint-detection tumor markers; By the porous plate that is coated with neuron specific enolase thing enzyme (NSE), cytokeratin fragment 21-1 (CYFRA21-1) and Dkkopf 1 (DKK1) monoclonal antibody; Horseradish peroxidase target NSE, CYFRA21-1 and DKK1, chromogenic substrate TMB and substrate stop buffer are formed; The every hole of said porous plate encapsulates NSE monoclonal antibody 1 ~ 4ug/mL; Every hole encapsulates CYFRA21-1 monoclonal antibody 1 ~ 2ug/mL; Every hole encapsulates DKK1 monoclonal antibody 1 ~ 2ug/mL.NSE, CYFRA21-1, three kinds of detection property of DKK1 antibody add in the ELISA Plate hole in the 4:4:2 ratio, and cumulative volume is 100 uL.
As a kind of preferred version, in the above-mentioned porous plate, the coating buffer in every hole is 100uL.
As a kind of preferred version, the working concentration extension rate of said horseradish peroxidase target NSE, CYFRA21-1 and DKK1 is 1:500 ~ 1:2500.
As a kind of preferred version, enzyme conjugates protection liquid is obtained by the phosphate buffer dilution of 0.01mol/L, pH7.4, contains 0.1% bovine serum albumin(BSA) and 0.1% thimerosal in the said phosphate buffer.
The preparation method of the enzyme-linked immunologic detecting kit of joint-detection tumor markers of the present invention comprises the steps: to prepare the porous plate that is coated with NSE, CYFRA21-1, DKK1 monoclonal antibody; , then above-mentioned NSE, CYFRA21-1, DKK1 monoclonal antibody dilution are joined in the hole NSE, CYFRA21-1, the dilution of DKK1 monoclonal antibody with pH 8 ~ 10 carbonate buffer solutions; 37 ℃ encapsulate 1h, and 5% bovine serum albumin solution is joined each hole of ELISA Plate, 37 ℃ of sealing 1 h; The sealing back is washed the version bat with phosphate buffer and is done, and it is stored in 4 ℃.
The enzyme-linked immunologic detecting kit of joint-detection tumor markers of the present invention can be applied in the detection of tumour correlating markings thing.
Compared with prior art, the present invention has following beneficial effect:
Kit according to the invention can detect two or three tumor associated antigen simultaneously, the specificity of detection and highly sensitive, and production cost is low.
Description of drawings
Fig. 1 is the synoptic diagram of ELISA Plate coated antibody in the detection kit of the present invention;
Fig. 2 is the stability analysis figure of detection kit of the present invention.
Embodiment
Come further to explain the present invention below in conjunction with embodiment, but embodiment does not do any type of qualification to the present invention.
The preparation process of embodiment 1 kit
(1) dilute NSE, CYFRA21-1, three kinds of detection property of DKK1 antibody in the 4:4:2 ratio adding ELISA Plate hole with carbonate buffer solution, cumulative volume is 100 uL, places 37 ℃, wrapper sheet 2h.
(2) clap liquid in the dry plate, add cleansing solution and wash plate, every hole 200uL, each 30s washs 5 times.
(3) with 5% bovine serum albumin solution sealase target, every hole 200uL, 37 ℃ of sealing 1 h; The sealing back is washed the version bat with phosphate buffer and is done, and it is stored in 4 ℃.
(4) clap liquid in the dry plate, add cleansing solution and wash plate, every hole 200uL, each 30s washs 5 times.
(5) vacuumize with Fresco Bag, 4 ℃ of placements are subsequent use.
Embodiment 2 double antibodies sandwich method enzyme linked immunological kits detect NSE, CK19, three kinds of antigens of DKK1
(1) add different serum to be checked in the reacting hole respectively, every example serum to be checked is established three parallel multiple holes, 5 times of serum dilutions to be checked, and every hole adds 100uL, places 37 ℃, 1h.
(2) clap liquid in the dry plate, add cleansing solution and wash plate, every hole 200uL, each 30s washs 5 times.
(3) each hole adds the enzyme labelled antibody after diluting, every hole 100uL, 37 ℃, incubation 1h.
(4) clap liquid in the dry plate, add cleansing solution and wash plate, every hole 200uL, each 30s washs 5 times.
(5) each hole adds colour developing liquid TMB, every hole 100uL, and 37 ℃ of reaction 10 min add stop buffer TMB, 450nm reading (Fig. 1).
Embodiment 3 double antibodies sandwich ELISA methods repeatability is analyzed
Choose high, medium and low 3 parts of different positive serum samples, use with a collection of kit and detect, every duplicate samples is parallel survey 8 holes respectively, carry out kit and criticize interior repeatability detection.
Table 1
Figure 238733DEST_PATH_IMAGE002
Choose high, medium and low 3 parts of different positive serum samples, detect with the double antibodies sandwich method diagnostic kit of 6 parts of different batches, the parallel survey of every duplicate samples 3 holes are carried out kit tippet repeatability and are detected.
Table 2
Figure 276091DEST_PATH_IMAGE004
Embodiment 3 kit stability analyses
Kit deposited in 37 ℃ of environment preserve, regularly detect, know till the maximal value drop by half of its quality index, it has been generally acknowledged that to deposit to be equivalent to 4-10 ℃ in one day and to deposit 1.5 months at 37 ℃.At least kept 7 days like 37 ℃ of this kits of table analysis, be equivalent to and preserve more than 10 months (Fig. 2) at 4 ℃.
Table 3
First day light absorption value Second day light absorption value The 3rd day light absorption value The 4th day light absorption value The 5th day light absorption value The 6th day light absorption value The 7th day light absorption value
1.243 1.064 1.057 1.077 0.79 1.056 0.607
1.256 1.122 1.076 1.084 0.813 1.054 0.82
1.295 1.101 1.131 1.067 0.821 1.07 0.753
1.319 1.1 1.27 1.054 0.766 0.882 0.639
1.21 1.091 1.311 1.089 0.813 0.914 0.685
Confirming of embodiment 5 kit gray areas
(1) take out 4 ℃ of subsequent use kits, the patients serum of the normal disease of 48 routine normal persons and 4 routine lungs is added to respectively in each hole, every example serum to be checked is established three parallel multiple holes, 5 times of serum dilutions to be checked, and every hole adds 100uL, places 37 ℃, 1h.
(2) clap liquid in the dry plate, add cleansing solution and wash plate, every hole 200uL, each 30s washs 5 times.
(3) each hole adds the enzyme labelled antibody after diluting, every hole 100uL, 37 ℃, incubation 1h.
(4) clap liquid in the dry plate, add cleansing solution and wash plate, every hole 200uL, each 30s washs 5 times.
(5) each hole adds colour developing liquid TMB, every hole 100uL, and 37 ℃ of reaction 10 min add stop buffer TMB, the 450nm reading.
It is following with multispecific antibody pulmonary cancer diagnosis kit measurement result to get 88 normal human serums at random:
88 OD value averages (X)=0.208 that normal human serum is measured, standard deviation (SD)=0.0589.So the cut off value (critical value) of its OD value for average (X)+3SD=0.208+0.1767=0.3847 then gray area OD value scope be exactly between 0 to 0.3847, meet the gray area patient and will check for suspicious.(the OD value that table 4:88 name normal human serum records).
The OD value that table 4:88 name normal human serum records
0.267 0.153 0.13 0.136 0.182 0.278 0.018 0.23
0.217 0.127 0.123 0.116 0.28 0.288 0.217 0.273
0.086 0.193 0.326 0.103 0.338 0.166 0.256 0.292
0.258 0.123 0.135 0.138 0.239 0.207 0.21 0.281
0.233 0.386 0.136 0.117 0.233 0.211 0.091 0.17
0.278 0.133 0.167 0.137 0.253 0.223 0.172 0.282
0.303 0.103 0.136 0.33 0.216 0.293 0.221 0.28
0.207 0.098 0.152 0.132 0.29 0.226 0.291 0.128
0.166 0.269 0.235 0.22 0.183 0.236 0.229 0.213
0.202 0.203 0.163 0.131 0.201 0.295 0.112 0.213
0.213 0.266 0.223 0.357 0.225 0.168 0.235 0.371

Claims (6)

1. the enzyme-linked immunologic detecting kit of a joint-detection tumor markers; It is characterized in that by the porous plate that is coated with NSE, CYFRA21-1 and DKK1 monoclonal antibody; Horseradish peroxidase target NSE, CYFRA21-1 and DKK1, chromogenic substrate TMB and substrate stop buffer are formed; The every hole of said porous plate encapsulates NSE monoclonal antibody 1 ~ 4ug/mL; Every hole encapsulates CYFRA21-1 monoclonal antibody 1 ~ 2ug/mL; Every hole encapsulates DKK1 monoclonal antibody 1 ~ 2ug/mL, and NSE, CYFRA21-1, three kinds of detection property of DKK1 antibody add in the ELISA Plate hole in the 4:4:2 ratio, and cumulative volume is 100 uL.
2. the enzyme-linked immunologic detecting kit of joint-detection tumor markers according to claim 1 is characterized in that in the said porous plate that the coating buffer in every hole is 100uL.
3. the enzyme-linked immunologic detecting kit of joint-detection tumor markers according to claim 1, its characteristic are that also the working concentration extension rate of said horseradish peroxidase target NSE, CYFRA21-1 and DKK1 is 1:500 ~ 1:2500.
4. the enzyme-linked immunologic detecting kit of joint-detection tumor markers according to claim 1; Its characteristic is that also enzyme conjugates protection liquid is obtained by the phosphate buffer dilution of 0.01mol/L, pH7.4, contains 0.1% bovine serum albumin(BSA) and 0.1% thimerosal in the said phosphate buffer.
5. the preparation method of the enzyme-linked immunologic detecting kit of any said joint-detection tumor markers of claim in the claim 1 ~ 4 is characterized in that comprising the steps: to prepare the porous plate that is coated with NSE, CYFRA21-1, DKK1 monoclonal antibody; , then above-mentioned NSE, CYFRA21-1, DKK1 monoclonal antibody dilution are joined in the hole NSE, CYFRA21-1, the dilution of DKK1 monoclonal antibody with pH 8 ~ 10 carbonate buffer solutions; 37 ℃ encapsulate 1h, and 5% bovine serum albumin solution is joined each hole of ELISA Plate, 37 ℃ of sealing 1 h; The sealing back is washed the version bat with phosphate buffer and is done, and it is stored in 4 ℃.
6. the application of enzyme-linked immunologic detecting kit in the detection of tumour correlating markings thing of any said joint-detection tumor markers of claim in the claim 1 ~ 4.
CN201110380835.0A 2011-11-25 2011-11-25 Enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on tumor marker Active CN102507951B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110380835.0A CN102507951B (en) 2011-11-25 2011-11-25 Enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on tumor marker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110380835.0A CN102507951B (en) 2011-11-25 2011-11-25 Enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on tumor marker

Publications (2)

Publication Number Publication Date
CN102507951A true CN102507951A (en) 2012-06-20
CN102507951B CN102507951B (en) 2014-11-19

Family

ID=46220057

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110380835.0A Active CN102507951B (en) 2011-11-25 2011-11-25 Enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on tumor marker

Country Status (1)

Country Link
CN (1) CN102507951B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105203773A (en) * 2015-09-28 2015-12-30 成都博奥新景医学科技有限公司 Quantitative detection kit for human Dickkopf-1 protein (DKK-1)
CN105588941A (en) * 2015-02-28 2016-05-18 苏州飞康生物医药有限公司 Enzyme-linked immunosorbent assay kit for detecting concentration of tumor marker DKK1
CN109085355A (en) * 2017-06-13 2018-12-25 中国医学科学院肿瘤医院 Serum protein markers combine the application in screening lung cancer and diagnosis and treatment
CN109959796A (en) * 2017-12-26 2019-07-02 复旦大学附属华山医院 A kind of enzyme-linked aptamers absorption detection kit of human serum DKK1

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004086045A1 (en) * 2003-03-28 2004-10-07 Medinnova As Method of measuring platelet-derived microvesicles (pmv) using a time-resolved fluorescence immunoassay (tr-fia)
CN1743849A (en) * 2004-09-03 2006-03-08 上海透景生命科技有限公司 Multi tumour tag parallel detecting method and kit
WO2008116592A1 (en) * 2007-03-23 2008-10-02 F. Hoffmann-La Roche Ag Apex as a marker for lung cancer
CN101503473A (en) * 2009-03-10 2009-08-12 广东药学院 Targeted polypeptide for diagnosing and treating lung cancer in vivo and in vitro and use thereof
CN101750497A (en) * 2008-12-17 2010-06-23 北京科美东雅生物技术有限公司 Enzymatic chemical luminous immunoassay quantitative determination reagent kit for simultaneously detecting various tumor markers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004086045A1 (en) * 2003-03-28 2004-10-07 Medinnova As Method of measuring platelet-derived microvesicles (pmv) using a time-resolved fluorescence immunoassay (tr-fia)
CN1743849A (en) * 2004-09-03 2006-03-08 上海透景生命科技有限公司 Multi tumour tag parallel detecting method and kit
WO2008116592A1 (en) * 2007-03-23 2008-10-02 F. Hoffmann-La Roche Ag Apex as a marker for lung cancer
CN101750497A (en) * 2008-12-17 2010-06-23 北京科美东雅生物技术有限公司 Enzymatic chemical luminous immunoassay quantitative determination reagent kit for simultaneously detecting various tumor markers
CN101503473A (en) * 2009-03-10 2009-08-12 广东药学院 Targeted polypeptide for diagnosing and treating lung cancer in vivo and in vitro and use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YONG-YUAN XU等: "Simultaneous Quadruple-Label Fluorometric Immunoassay of Thyroid-Stimulating Hormone, 17a-Hydroxyprogesterone, Immunoreactive Trypsin, and Creatine Kinase MM Isoenzyme in Dried Blood Spots", 《CLINICAL CHEMISTRY》, vol. 38, no. 10, 31 October 1992 (1992-10-31) *
夏明成等: "血浆长链DNA在肺癌患者检测的研究", 《中华医学实践杂志》, vol. 5, no. 8, 31 December 2006 (2006-12-31) *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105588941A (en) * 2015-02-28 2016-05-18 苏州飞康生物医药有限公司 Enzyme-linked immunosorbent assay kit for detecting concentration of tumor marker DKK1
CN105203773A (en) * 2015-09-28 2015-12-30 成都博奥新景医学科技有限公司 Quantitative detection kit for human Dickkopf-1 protein (DKK-1)
CN109085355A (en) * 2017-06-13 2018-12-25 中国医学科学院肿瘤医院 Serum protein markers combine the application in screening lung cancer and diagnosis and treatment
CN109959796A (en) * 2017-12-26 2019-07-02 复旦大学附属华山医院 A kind of enzyme-linked aptamers absorption detection kit of human serum DKK1
CN109959796B (en) * 2017-12-26 2022-05-10 复旦大学附属华山医院 Human serum DKK1 enzyme-linked aptamer adsorption detection kit

Also Published As

Publication number Publication date
CN102507951B (en) 2014-11-19

Similar Documents

Publication Publication Date Title
US11959912B2 (en) Fluorescence immunochromatographic detection card and a preparation method therefor and use thereof
CN106885908B (en) The detection kit and its detection method of blood-serum P SMD4 albumen and application
CN102435748B (en) Double-antibody sandwich enzymelinked immunosorbent detection kit and preparation method thereof
CN106053794A (en) Reagent card for accurately detecting test object, kit and application
CN102841207A (en) Fluorescent immune chromatographic test strip for quantitively detecting troponin I and preparation method thereof
CN101424661B (en) Serodiagnosis model establishing method for active tuberculosis disease
CN102507951B (en) Enzyme-linked immuno sorbent assay (ELISA) kit for performing joint detection on tumor marker
CN107765002A (en) A kind of colloidal gold immuno-chromatography test paper strip and its preparation method and application
CN107102154B (en) Micro-array chip, preparation method, kit and the detection method of protein expression in a kind of detection cellular stress
He et al. Development of a lateral flow immunoassay for the rapid diagnosis of invasive candidiasis
CN109580958A (en) The fluorescence and colorimetric dual signal detection kit and detection method of a kind of cardiac muscle troponin I
CN108535485A (en) A kind of time-resolved fluoroimmunoassay chromatograph test strip and preparation method quantitatively detecting CA153 in blood
CN111999507A (en) Fluorescence immunochromatography test paper for detecting novel coronavirus antibody
CN110187109A (en) A kind of autoantibody joint-detection ELISA kit for Grades of Gastric Cardia Adenocarcinoma early screening
CN105492907B (en) New detection method
CN108020666A (en) It is a kind of can simultaneous quantitative detection blood in CEA and CA19-9 magnetic immuno-chromatographic test paper strip and preparation method
Jiang et al. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases
CN111948389A (en) Time-resolved fluorescence immunochromatographic test strip for detecting influenza A and B viruses and novel coronavirus antigens and preparation method thereof
Liu et al. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum
CN105548546B (en) Lung cancer screening kit
EP3640644B1 (en) Target marker gp73 for detecting steatohepatitis and detection application method
CN103901205B (en) Cystatin SN and CYFRA21-1 application in preparation diagnosis and indication esophageal carcinoma mark
CN110687293A (en) Kit for detecting gastric cancer antigen MG7-Ag and application thereof
WO2023087550A1 (en) Kit for detecting sars-cov-2 antigen and detection method
He et al. Evaluation of a diagnostic flow chart applying medical thoracoscopy, adenosine deaminase and T-SPOT. TB in diagnosis of tuberculous pleural effusion

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 510006 Guangdong City, Guangzhou province outside the University of East Ring Road, No. 280

Patentee after: Guangdong Pharmaceutical University

Address before: 510006 Guangdong City, Guangzhou province outside the University of East Ring Road, No. 280

Patentee before: Guangdong Pharmaceutical University